Showing results (1131-1140 of 1,708) with videos related to
Sort By:
Pageof 171
Circulation. Cardiovascular Interventions|January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary InterventionNeal N Sawlani, Robert A Harrington, Gregg W Stone, et al.Circulation. Cardiovascular Interventions|February 4, 2016
Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease RegistrySubhash Banerjee, Karan Sarode, Atif Mohammad, et al.Vascular Pharmacology|January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromesWilliam A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.Journal of the American Heart Association|February 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized TrialRahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, et al.American Heart Journal|May 27, 2026
Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular diseasePh Gabriel Steg, Shaun G Goodman, J Wouter Jukema, et al.Clinical Cardiology|July 4, 2012
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelinesPei-Hsiu Huang, Charles X Kim, Amir Lerman, et al.European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.Circulation|March 21, 2015
Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United StatesDhaval Kolte, Sahil Khera, Wilbert S Aronow, et al.JACC. Cardiovascular Interventions|July 11, 2020
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized TrialsVarunsiri Atti, Yeongjin Gwon, Mahesh Anantha Narayanan, et al.Nature Medicine|June 24, 2023
The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialDeepak L Bhatt, Harold E Bays, Michael Miller, et al.Pageof 171